Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments
Sponsor: Centre Hospitalier Metropole Savoie
Summary
The goal of this clinical trial is to learn about the effect of sarcopenic status on the occurrence of treatment-related toxicity during the first course of anti-cancer treatment in several types of cancers. The main question it aims to answer is : Is sarcopenia a predictive marker for the occurrence of toxicity in the initial phase of cancer treatment? The evaluation will focus on the body composition of the participants, assessed by impedancemetry, and on their muscular performance by standardized physical tests.
Official title: Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments. Prospective Cohort Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
700
Start Date
2024-06-24
Completion Date
2028-05-01
Last Updated
2024-07-18
Healthy Volunteers
No
Interventions
Sarcopenia diagnostic test
the study-specific measurements for the assessment of sarcopenia (impedancemetry, grip strength and chair rise test) as well as the distribution of actimeters to patients.
Locations (1)
Centre Hospitalier Metropole Savoie
Chambéry, France